Evidence map›Paper›PMID 34443566›Full record

ArticleMolecules (Basel, Switzerland)2021

Re-Evaluations of Zr-DFO Complex Coordination Chemistry for the Estimation of Radiochemical Yields and Chelator-to-Antibody Ratios of

Ryota Imura, Hiroyuki Ida, Ichiro Sasaki, Noriko S Ishioka, Shigeki Watanabe

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. The Evaluation of (1Molecules (Basel, Switzerland) · 2025
    Article
  2. Article
  3. Article
  4. Article
  5. From Desferrioxamine B Umpolung to an Enantiopure Bifunctional Chelator forChemistry (Weinheim an der Bergstrasse, Germany) · 2025
    Article
  6. A Snake Toxin Derivative for Treatment of Hyponatremia and Polycystic Kidney Diseases.Journal of the American Society of Nephrology : JASN · 2025
    Article
  7. [EJNMMI radiopharmacy and chemistry · 2024
    Article
  8. Article
  9. Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Ryota ImuraResearch Center for Advanced Science and Technology, The University of Tokyo, 4-6-1 Komaba, Meguro-ku, Tokyo 153-8904, Japan.ORCID 0000-0002-9050-4901
Hiroyuki IdaJFE Engineering Corporation, 2-1 Suehiro-cho, Tsurumi-ku, Yokohama 230-8611, Japan.
Ichiro SasakiDepartment of Radiation-Applied Biology Research, Takasaki Advanced Radiation Research Institute, National Institute of Quantum and Radiological Science and Technology (QST), 1233 Watanuki, Takasaki, Gunma 370-1292, Japan.
Noriko S IshiokaDepartment of Radiation-Applied Biology Research, Takasaki Advanced Radiation Research Institute, National Institute of Quantum and Radiological Science and Technology (QST), 1233 Watanuki, Takasaki, Gunma 370-1292, Japan.
Shigeki WatanabeDepartment of Radiation-Applied Biology Research, Takasaki Advanced Radiation Research Institute, National Institute of Quantum and Radiological Science and Technology (QST), 1233 Watanuki, Takasaki, Gunma 370-1292, Japan.ORCID 0000-0002-8556-8580

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

(1) Background: Deferoxamine B (DFO) is the most widely used chelator for labeling of zirconium-89 (

Indexed as

Chelating AgentsDeferoxaminePositron-Emission TomographyRadioisotopesZirconiumAntibodies, MonoclonalCoordination ComplexesRadiopharmaceuticalsAntibodies, MonoclonalChelating AgentsCoordination ComplexesDeferoxamineRadioisotopesRadiopharmaceuticalsZirconiumZirconium-8989Zrantibody labelingcoordination chemistrydeferoxamineimmune-PETradioimmunoconjugatetheranosticsZr-DFO complex

Identifiers

PMID34443566
PMCPMC8401698

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.